First off Label Endovascular Clinical Experience to Treat Diffuse Cerebral Venous Sinus Thrombosis Using the INARI FlowTriever System: Case Report

Anticoagulation with heparin is the current mainstay treatment for Cerebral Venous Sinus Thrombosis (CVST). Endovascular treatment is increasingly being used to treat patients with CVST who are non-responsive to anticoagulation. These more aggressive interventions include catheter-based local chemic...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in neurology 2021-12, Vol.12, p.778842
Main Authors: Bushnaq, Saif, Kareem, Samer Abdul, Liaw, Nicholas, Alenzi, Bader, Ahmed, Muhammad Khaleeq, Bushnaq, Merna, Zaidat, Osama O
Format: Article
Language:English
Subjects:
case report
cerebral venous sinus thrombosis
endovascular treatment
INARI FlowTriever system
intervention
Neurology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anticoagulation with heparin is the current mainstay treatment for Cerebral Venous Sinus Thrombosis (CVST). Endovascular treatment is increasingly being used to treat patients with CVST who are non-responsive to anticoagulation. These more aggressive interventions include catheter-based local chemical thrombolysis, balloon angioplasty and mechanical thrombectomy with uncertain safety and efficacy. Here we describe the first reported clinical experience using the INARI FlowTriever system to treat a patient presented with focal weakness and found to have diffuse CVST.
ISSN:1664-2295
1664-2295
DOI:10.3389/fneur.2021.778842